1,058
Views
11
CrossRef citations to date
0
Altmetric
Review

Are vasopressors useful in toxin-induced cardiogenic shock?

&
Pages 285-304 | Received 28 Jun 2016, Accepted 05 Jan 2017, Published online: 03 Feb 2017
 

Abstract

Objective: Overdoses with cardio-depressive medications can result in toxin-induced cardiogenic shock (TICS), a life-threatening condition characterized by severe hypotension and ineffective tissue perfusion. Vasopressors are often employed in the treatment of shock to increase heart rate and blood pressure. We sought to conduct a systematic review of the literature to evaluate the effectiveness of vasopressors in improving hemodynamic function and survival in the treatment of TICS.

Data sources: We searched PubMed, EMBASE, TOXLINE, and International Pharmaceutical Abstracts.

Study selection: We included studies evaluating the use of vasopressors in humans or animals with TICS. We limited human study types to randomized controlled trials, clinical trials, observational studies, and case reports.

Data extraction: Our search yielded 913 citations and 144 of these met our inclusion criteria. 130 were human case reports and 14 were animal studies.

Data synthesis: Human case report data showed vasopressors were ineffective more often than they were partially or fully effective. In the majority of animal studies, vasopressor treatment failed to improve hemodynamic parameters and resulted in decreased survival.

Conclusions: Human case reports and controlled animal experiments lead to different conclusions about vasopressors in TICS. Most animal studies indicate that vasopressors impair hemodynamic function and increase mortality. In contrast, human case reports suggest that vasopressors are often ineffective but not necessarily harmful.

Acknowledgements

We would like to sincerely thank Mary Wittenbreer for her help in conducting the literature search. This project would not have been possible without her remarkable skill and expertise.

Disclosure statement

The authors have no disclosures or declarations of interest to report.

Funding

This project was not supported by any grants or monetary awards.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.